Virbac
€308.00Change from previous close: +0.49%Absolute change: +€1.50
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- €2.58B
- Enterprise value
- €2.77B
- P/E (trailing 12 months)
- 16.6
- Forward P/E
- 14.4
- PEG
- 1.20
- Price/book
- 2.12
- Price/sales
- 1.73
- EV/EBITDA
- 9.07
- EV/revenue
- 1.85
Profitability and growth
- Gross margin
- 67.2%
- Operating margin
- 15.8%
- Net margin
- 10.4%
- ROE
- 13.6%
- ROA
- 7.6%
- ROIC
- 11.7%
Financial health
- Total cash
- €172.53M
- Total debt
- €361.47M
- Debt/equity
- 0.30
- Current ratio
- 1.77
- Quick ratio
- 0.93
- Altman Z-Score
- 3.40
- Piotroski F-Score
- 5.00
Dividends
- Annual dividend per share
- €1.45
- Dividend yield
- 0.5%
- Ex-dividend date
- July 2, 2026
Analysts and estimates
- Average price target
- €412.75
- Analysts with a price target
- 8
- Consensus
- Strong buy
Shares and trading
- Beta
- 0.79
- Average volume
- 7.53K
- Shares outstanding
- 8.38M
- Float
- 4.13M
- Institutional ownership
- 22.3%
- Insider ownership
- 50.2%